Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Sorrento RTX Market Model Indicates A Higher NPV Than The Current Price Of Shares.


RTX has high potential and is probably the most undervalued asset of Sorrento.

It is a non-opiod solution for terminal pain in cancer patients.

Estimates are conservative.

In our recent article, we talk about how RTX is an under-appreciated asset of Sorrento. Here, we model future opportunity and use a 20% discount rate to reach NPV of RTX. 

We arrived at an NPV of $7.56 which implies a 41% increase from the current share price.

This is just one part of our sum-of-the-parts valuation showing a severe undervaluation of the company. 

Disclosure: I am/we are long SRNE.